Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sulindac-induced aseptic meningitis

Z K Ballas, S T Donta

    Archives of Internal Medicine
    |January 1, 1982
    PubMed
    Summary

    A patient with systemic lupus erythematosus experienced severe adverse reactions to sulindac, including neurological and respiratory symptoms. These reactions resolved quickly, suggesting a non-prostaglandin-mediated mechanism.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cryopreservation of CTLL, a murine IL2-dependent cell line.

    Immunology today·2014
    Same author

    Complement fragments suppress lymphocyte immune responses.

    Immunology today·2014
    Same author

    Treatment of patients with persistent symptoms and a history of Lyme disease.

    The New England journal of medicine·2002
    Same author

    Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

    Journal of immunology (Baltimore, Md. : 1950)·2001
    Same author

    TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease.

    Alcohol (Fayetteville, N.Y.)·2001
    Same author

    CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.

    International immunology·2001

    Area of Science:

    • Rheumatology
    • Clinical Pharmacology
    • Neuroimmunology

    Background:

    • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) like sulindac are sometimes used in SLE management.
    • Adverse drug reactions require careful monitoring and characterization.

    Observation:

    • A 22-year-old female SLE patient developed acute, severe symptoms within an hour of sulindac administration.
    • Symptoms included generalized pruritus, dyspnea, pleuritic chest pain, visual disturbances, photophobia, nuchal rigidity, headache, and fever (39.4°C).
    • Cerebrospinal fluid (CSF) analysis revealed elevated protein and polymorphonuclear pleocytosis.

    Findings:

    • The patient's symptoms resolved completely within 24 hours after discontinuing sulindac.
    • The adverse reaction was unlikely due to prostaglandin synthesis inhibition, as the patient tolerated aspirin.
    • This suggests an idiosyncratic or alternative mechanism of sulindac-induced toxicity.

    Implications:

    • Clinicians should be aware of potential severe, acute adverse reactions to sulindac in SLE patients.
    • Further investigation into the specific mechanism of this sulindac-related adverse event is warranted.
    • This case highlights the importance of considering non-prostaglandin-mediated pathways in NSAID-induced toxicity.

    Related Experiment Videos